Order Article Reprints

Mazzola GC, Vincini MG, Rondi E, Ronci G, Vigorito S, Zaffaroni M, Corrao G, Gallo S, Zerini D, Durante S, et al. CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study. Applied Sciences. 2023; 13(12):7273. https://doi.org/10.3390/app13127273

Mazzola, Giovanni Carlo, Maria Giulia Vincini, Elena Rondi, Giuseppe Ronci, Sabrina Vigorito, Mattia Zaffaroni, Giulia Corrao, Salvatore Gallo, Dario Zerini, Stefano Durante, and et al. 2023. "CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study" Applied Sciences 13, no. 12: 7273. https://doi.org/10.3390/app13127273

Mazzola, G. C., Vincini, M. G., Rondi, E., Ronci, G., Vigorito, S., Zaffaroni, M., Corrao, G., Gallo, S., Zerini, D., Durante, S., Mistretta, F. A., Luzzago, S., Ferro, M., Vavassori, A., Cattani, F., Musi, G., De Cobelli, O., Petralia, G., Orecchia, R., ... Jereczek-Fossa, B. A. (2023). CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study. Applied Sciences, 13(12), 7273. https://doi.org/10.3390/app13127273